Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2142
2021 1445
2022 580
2023 242
2024 62

Text availability

Article attribute

Article type

Publication date

Search Results

3,932 results

Results by year

Filters applied: . Clear all
Page 1
Hydroxychloroquine and COVID-19.
Sinha N, Balayla G. Sinha N, et al. Postgrad Med J. 2020 Sep;96(1139):550-555. doi: 10.1136/postgradmedj-2020-137785. Epub 2020 Apr 15. Postgrad Med J. 2020. PMID: 32295814 Free PMC article. Review.
Hydroxychloroquine and chloroquine are medications that have been used for a long time. ...Several in vitro studies have proven their effectiveness on severe acute respiratory syndrome virus and currently both in vitro and in vivo studies have been conducted on 2019 novel …
Hydroxychloroquine and chloroquine are medications that have been used for a long time. ...Several in vitro studies have proven their …
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Gautret P, et al. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. Int J Antimicrob Agents. 2020. PMID: 32205204 Free PMC article. Clinical Trial.
BACKGROUND: Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. ...CONCLUSION: Despite its small sample size, our survey shows that hydroxychloroquine …
BACKGROUND: Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be …
Hydroxychloroquine and COVID-19: The endgame!
Deplanque D. Deplanque D. Therapie. 2023 Jul-Aug;78(4):343-344. doi: 10.1016/j.therap.2023.06.003. Epub 2023 Jun 7. Therapie. 2023. PMID: 37321943 Free PMC article. No abstract available.
Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
Ibáñez S, Martínez O, Valenzuela F, Silva F, Valenzuela O. Ibáñez S, et al. Clin Rheumatol. 2020 Aug;39(8):2461-2465. doi: 10.1007/s10067-020-05202-4. Epub 2020 Jun 3. Clin Rheumatol. 2020. PMID: 32495226 Free PMC article. Review.
The pandemic of the new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has urged the nations to an unprecedented world-wide reaction, including an accelerated exploration of …
The pandemic of the new coronavirus, known as severe acute respiratory syndrome coronavirus 2 …
COVID-19 challenges and its therapeutics.
Rehman SU, Rehman SU, Yoo HH. Rehman SU, et al. Biomed Pharmacother. 2021 Oct;142:112015. doi: 10.1016/j.biopha.2021.112015. Epub 2021 Aug 5. Biomed Pharmacother. 2021. PMID: 34388532 Free PMC article. Review.
COVID-19, an infectious disease, has emerged as one of the leading causes of death worldwide, making it one of the severe public health issues in recent decades. nCoV, the novel SARS coronavirus that causes COVID-19, has brought together …
COVID-19, an infectious disease, has emerged as one of the leading causes of death worldwide, making it one of the severe publ …
The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19.
Aljadeed R. Aljadeed R. J Pharm Pract. 2022 Dec;35(6):971-978. doi: 10.1177/0897190021997399. Epub 2021 Apr 28. J Pharm Pract. 2022. PMID: 33906514 Review.
On March 11th, the World Health Organization (WHO) announced the unprecedented outbreak of "severe acute respiratory syndrome coronavirus 2" (SARS-CoV-2) to be a pandemic. ...Here, we summarize recent evidence regardi …
On March 11th, the World Health Organization (WHO) announced the unprecedented outbreak of "severe acute respiratory …
Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications.
Kumar R, Sharma A, Srivastava JK, Siddiqui MH, Uddin MS, Aleya L. Kumar R, et al. Environ Sci Pollut Res Int. 2021 Aug;28(30):40431-40444. doi: 10.1007/s11356-020-12200-1. Epub 2021 Jan 15. Environ Sci Pollut Res Int. 2021. PMID: 33447984 Free PMC article. Review.
The outbreak of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected the entire world with its infectious spread and mortality rate. The severe cases of coronavirus disease 2019 (C …
The outbreak of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 …
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
Meo SA, Klonoff DC, Akram J. Meo SA, et al. Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4539-4547. doi: 10.26355/eurrev_202004_21038. Eur Rev Med Pharmacol Sci. 2020. PMID: 32373993 Free article. Review.
OBJECTIVE: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also called COVID-19, has caused a pandemic which has swiftly involved the entire world and raised great public health c …
OBJECTIVE: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 …
COVID-19 diagnosis and management: a comprehensive review.
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò FE. Pascarella G, et al. J Intern Med. 2020 Aug;288(2):192-206. doi: 10.1111/joim.13091. Epub 2020 May 13. J Intern Med. 2020. PMID: 32348588 Free PMC article. Review.
The disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19), presents flu-like symptoms which can become serious in high-risk individuals. Here, we provide an overview of the known clinical features and treatment options for …
The disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19), presents flu-like symptoms …
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak.
Nicolò M, Ferro Desideri L, Bassetti M, Traverso CE. Nicolò M, et al. Int Ophthalmol. 2021 Feb;41(2):719-725. doi: 10.1007/s10792-020-01593-0. Epub 2020 Sep 18. Int Ophthalmol. 2021. PMID: 32946004 Free PMC article. Review.
PURPOSE: The current coronavirus disease 2019 (COVID-19) has been declared by the World Health Organization a global pandemic. ...In this review, we will discuss the optimal dosages recommended for COVID-19 patients when treated with HCQ and CQ. …
PURPOSE: The current coronavirus disease 2019 (COVID-19) has been declared by the World Health Organization a global pa …
3,932 results